Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches
Natália Fernanda Frediani Pirolla, Victor S. Batista, Flávia Pereira Dias Viegas, et al.
Current Drug Targets (2020) Vol. 22, Iss. 5, pp. 505-538
Closed Access | Times Cited: 9

Showing 9 citing articles:

Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1702-1714
Open Access | Times Cited: 43
Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
Anna Sampietro, F. Javier Pérez-Areales, Paula Felippe Martinez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 545-545
Open Access | Times Cited: 32
Design, Synthesis, and Invitro Pharmacological Evaluation of Novel Resveratrol Surrogate Molecules against Alzheimer's Disease
Arunkumar Subramanian, Tamilanban Thamaraikani, Vinoth Kumarasamy, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 9
Closed Access | Times Cited: 5
Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy
Honghua Zhang, Yan Peng, Linsheng Zhuo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114695-114695
Closed Access | Times Cited: 15
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
Caterina Pont, Tiziana Ginex, Christian Griñán‐Ferré, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113779-113779
Open Access | Times Cited: 13
Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 1
Structure‐based design of new N‐benzyl‐piperidine derivatives as multitarget‐directed AChE/BuChE inhibitors for Alzheimer's disease
Raissa Alves da Conceição, Natalia Lidmar von Ranke, Luciana Abrantes Pontes de Azevedo, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 11, pp. 1734-1748
Open Access | Times Cited: 2
A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer’s Disease Mice Models
Júlia Jarné‐Ferrer, Christian Griñán‐Ferré, Aina Bellver‐Sanchís, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 908-908
Open Access | Times Cited: 4
Study on Multi-Target Synergistic Treatment of Alzheimer’s Disease Based on Metal Chelators
Rui Shen, Xiaodi Kou, Ai‐Hong Yang, et al.
Current Drug Targets (2022) Vol. 24, Iss. 2, pp. 131-150
Closed Access | Times Cited: 2
Page 1

Scroll to top